Daniel Liu, MD
Plastic and Reconstructive Surgery · Zion, ILNPI 1104931286
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $37,925 of the $47,113 with a category attached, or 80.5%. 31 manufacturers reported payments, led by Surgalign Spine Technologies, Inc. at 48.6% of the total. Reporting peaked in 2019 at $23,621 and has fallen 89.7% since, to $2,444 in 2025. Among plastic and reconstructive surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $329.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgalign Spine Technologies, Inc.$23K
- RTI Surgical, Inc$20K
- BD$988
- W. L. Gore & Associates, Inc.$900
- Novartis$365
- Medtronic$205
- plus $2K from 25 others
What the payments were for
- Consulting fees$37,92580%
- Speaking & faculty fees$5,65012%
- Travel & lodging$6871%
- Food & beverage$2,8516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgalign Spine Technologies, Inc. | 7 | $22,909 |
| RTI Surgical, Inc | 30 | $20,118 |
| BD | 2 | $988 |
| W. L. Gore & Associates, Inc. | 1 | $900 |
| Novartis | 20 | $365 |
| Medtronic | 6 | $205 |
| Merck | 8 | $203 |
| Amgen | 9 | $182 |
| Lilly USA, LLC | 6 | $148 |
| Pfizer | 7 | $127 |
| Astellas Pharma US Inc | 5 | $102 |
| Eisai Inc. | 5 | $91 |
| TELA Bio, Inc. | 3 | $90 |
| Daiichi Sankyo Inc. | 4 | $86 |
| AbbVie | 4 | $78 |
| Mentor Worldwide LLC | 3 | $73 |
| Davol Inc. | 1 | $49 |
| Bayer | 2 | $46 |
| Taiho Oncology, Inc. | 2 | $45 |
| Cumberland Pharmaceuticals, Inc. | 3 | $43 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $37 |
| AstraZeneca | 3 | $35 |
| Springworks Therapeutics, Inc. | 1 | $34 |
| EMD Serono, Inc. | 1 | $28 |
| Seagen Inc. | 1 | $25 |
| Array Biopharma Inc | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Vertex | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Acacia Pharma Inc | 2 | $16 |
| Puma Biotechnology, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CORTIVA ALLOGRAFT DERMIS$31,293
- CORTIVA TAILORED ALLOGRAFT DERMIS$10,750
- Product in Development$900
- ALLOGRAFT$827
How this compares
$47,113 in reported general payments places this provider in the 90th percentile of 126 plastic and reconstructive surgery providers in Illinois.
See all plastic and reconstructive surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Zion
- John KimChicago$7.3M
- Mark SiscoNorthbrook$309K
- Steven SigaloveGlen Ellyn$218K
- Matthew EndaraJoliet$204K
- Brian MaileySpringfield$182K
- Julius FewChicago$148K
- Eleanor BucholzMaywood$63K
- Gregory DumanianChicago$50K
- Laurie CasasGlenview$36K
- Alan ChenJoliet$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.